Drug Trial Radar · NCT06116617
A Phase 1 Study to Evaluate the Safety, Tolerability, PK/PD of SRSD107 in Healthy Participants
Last checked: Nov 19, 2026Latest source record: May 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Jan 23, 2024
Primary completion
Dec 9, 2024
Study completion Apr 30, 2025
Sponsor
- Lead sponsor
- Sirius Therapeutics Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Nov 3, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary aim of this study is to evaluate safety and tolerability data when SRSD107 is administered as single SC injections to healthy participants. This information, along with PK/PD data, will help establish the appropriate doses and dosing regimen for future studies in patients.
Conditions
- Thrombosis
Interventions
SRSD107Drug
SRSD107 is a synthetic, chemically modified double-stranded, small interfering ribonucleic acid (siRNA).
PlaceboDrug
Sodium chloride
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of adverse events (AEs)Time frame: up to 168 days post last dose
- Proportion of Serious Adverse Events (SAEs)Time frame: up to 168 days post last dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Linear Clinical Research
Perth, Other (Non U.s.), Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.